Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Sodium × Clear all

Phase

Phase NA 2 Phase EARLY_PHASE1 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Cisplatin 1307 Carboplatin 1226 Cyclophosphamide 1165 Gemcitabine 1060 Bevacizumab 1057 Paclitaxel 1046 Radiotherapy 1033 Docetaxel 954 pembrolizumab 886 Oxaliplatin 803 Capecitabine 787 Fluorouracil 740 Rituximab 643 Doxorubicin 582 Nivolumab 579 Dexamethasone 577 Etoposide 574 Irinotecan 550 Leucovorin 511 Pemetrexed 437 Drug Therapy 415 Cetuximab 408 Cytarabine 406 Trastuzumab 401 Magnetic Resonance Spectroscopy 388 Filgrastim 384 Prednisone 369 Lenalidomide 352 Bortezomib 348 Temozolomide 343

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01031420 2019-09-17

Dose Dense MVAC for Muscle Invasive Bladder Cancer

Fox Chase Cancer Center

Phase 2 Completed

54 enrolled 7 charts

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡